Gene therapy in rheumatoid arthritis: How to target joint destruction?

Arthritis Research

Volumn 1, Issue 1, 1999, Pages 5-9

  Pap, T ^a   Muller Ladner U ^a   Gay, R ^a   Gay, S ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; BETA1 INTEGRIN; CATHEPSIN; COLLAGENASE 3; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERSTITIAL COLLAGENASE; MATRIX METALLOPROTEINASE; METHOTREXATE; MONOCLONAL ANTIBODY; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN C JUN; PROTEIN P53; RAF PROTEIN; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR; VASCULAR CELL ADHESION MOLECULE 1; VERY LATE ACTIVATION ANTIGEN 3; VERY LATE ACTIVATION ANTIGEN 5; VIRUS VECTOR;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; CARTILAGE; CELL ADHESION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG TARGETING; ENZYME RELEASE; FIBROBLAST; GENE OVEREXPRESSION; GENE TARGETING; GENE THERAPY; GENE TRANSFER; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; JOINT DESTRUCTION; MOUSE; NONHUMAN; NOTE; PROTEIN EXPRESSION; RETROVIRUS; RHEUMATOID ARTHRITIS; SYNOVIOCYTE; SYNOVIUM; TARGET CELL;

ANIMALS; ARTHRITIS, RHEUMATOID; GENE THERAPY; HUMANS; JOINTS;

EID: 0033281622     PISSN: 14659905     EISSN: None     Source Type: Journal    
DOI: 10.1186/ar3     Document Type: Note

References (37)

1. TNF blockade in rheumatoid arthritis: Implications for therapy and pathogenesis
2. Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein
3. Lessons learned from gene transfer approaches
4. Inhibition of the production and effects of interleukin-1 and tumor necrosis factor alpha in rheumatoid arthritis
5. Human IL-1Ra gene transfer into human synovial fibroblasts is chondroprotective
6. Gene transfer of cytokine inhibitors into human synovial fibroblasts in the SCID mouse model
7. Clinical trial to assess the safety, feasibility, and efficacy of transferring a potentially anti-arthritic cytokine gene to human joints with rheumatoid arthritis
8. Clinical improvement and radiological deterioration in rheumatoid arthritis: Evidence that the pathogenesis of synovial inflammation and articular erosion may differ
9. Synovial fibroblasts of patients with rheumatoid arthritis attach to and invade normal human cartilage when engrafted into SCID mice
10. Somatic mutations in the p53 tumor suppressor gene in rheumatoid arthritis synovium
11. Analysis of the p53 tumor suppressor gene in rheumatoid arthritis synovial fibroblasts
12. Activation of synovial fibroblasts in RA: Lacking expression of the tumor suppressor PTEN at sites of invasive growth and destruction
13. Downregulation but no mutation of novel tumor suppressor PTEN in aggressively invading rheumatoid arthritis fibroblasts (RA-SF)
14. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer
15. Oncogenes in rheumatoid synovium
16. Constitutive expression of c-fos and c-jun, overexpression of ets-2, and reduced expression of metastasis suppressor gene nm23- H1 in rheumatoid arthritis
17. Spontaneous expression of immediately-early response genes c-fos and egr-1 in collagenase-producing rheumatoid synovial fibroblasts
18. The AP-1 site and MMP gene regulation: What is all the fuss about?
19. Direct evidence of high DNA binding activity of transcription factor AP-1 in rheumatoid arthritis synovium
20. Effect of dominant negative mutants of raf-1 and c-myc on rheumatoid arthritis synovial fibroblasts in the SCID mouse model
21. NF-kappaB activation provides the potential link between inflammation and hyperplasia in the arthritic joint
22. AP-1 and NF-kappaB regulation in rheumatoid arthritis and murine collagen-induced arthritis
23. NF-kappa B as a target for anti-inflammatory gene therapy: Suppression of inflammatory responses in monocytic and stromal cells by stable gene transfer of I kappa B alpha cDNA
24. An immunohistochemical and immunoelectron microscopic study of adhesion molecules in synovial pannus formation in rheumatoid arthritis
25. Increased expression of integrins on fibroblast-like synoviocytes from rheumatoid arthritis in vitro correlates with enhanced binding to extracellular matrix proteins
26. Integrins, oncogenes, and anchorage independence
27. Cell adhesion induces expression of growth-associated genes in suspension-arrested fibroblasts
28. Integrin-dependent induction of early growth response genes in capillary endothelial cells
29. Alpha 4/beta 1 integrin (VLA-4) ligands in arthritis. Vascular cell adhesion molecule-1 expression in synovium and on fibroblast-like synoviocytes
30. Expression of vascular cell adhesion molecule-1 mRNA and protein in rheumatoid synovium demonstrated by in situ hybridization and immunohistochemistry
31. The role of VCAM-1 molecule in the pathogenesis of rheumatoid synovitis
32. Soluble VCAM-1 induces chemotaxis of Jurkat and synovial fluid T cells bearing high affinity very late antigen-4
33. T cells bound by vascular cell adhesion molecule-1/CD106 in synovial fluid in rheumatoid arthritis: Inhibitory role of soluble vascular cell adhesion molecule-1 in T cell activation
34. Review: Angiogenesis: Implications for rheumatoid arthritis
35. Synovial fluid CD146 (MUC18), a marker for synovial membrane angiogenesis in rheumatoid arthritis
36. Gene therapy in osteoarticular diseases: Where are we?
37. Expression of sentrin, a novel anti-apoptotic molecule at sites of synovial invasion in rheumatoid arthritis